Its best-documented effect is a meaningful reduction of visceral adipose tissue the deep abdominal fat in people with HIV-associated lipodystrophy, alongside improved lipid profiles, over roughly 612 months of daily use [3] [4]
Such an innate cytoprotective defensive healing system will correspondingly establish the consistent beneficial effects of stable gastric pentadecapeptide BPC 157 therapy on angiogenesis and the NO-system [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40]
Common Subcutaneous Injection Sites Lower abdomen, avoiding the area two inches around the navel Upper outer thighs Upper glutes Upper outer arms Certain peptides, such as BPC-157 or TB-4, may be injected closer to an injury site if advised by your provider
As you say, Wedgewood, a lot of contradictory opinions
Adjusting medication regimens or dietary changes may be necessary for those on medications that affect B12 absorption